Peter Mudry Selected Research

Peter Mudry Research Topics

12	Neoplasms (Cancer) 01/2022 - 07/2006
6	Sarcoma (Soft Tissue Sarcoma) 11/2019 - 04/2016
4	Rhabdomyosarcoma 11/2019 - 01/2011
3	Osteosarcoma (Osteogenic Sarcoma) 07/2016 - 05/2012
2	Myofibromatosis 09/2018 - 10/2017
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Residual Neoplasm 01/2022
1	Giant Cell Tumor of Bone 07/2021
1	Infections 11/2019
1	Neutropenia 11/2019
1	Pain (Aches) 11/2019
1	Thrombocytopenia (Thrombopenia) 11/2019
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019
1	Neuroblastoma 01/2019
1	Nijmegen Breakage Syndrome 10/2017
1	Candidiasis (Moniliasis) 01/2017
1	Aspergillosis 01/2017
1	Invasive Candidiasis 01/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 06/2016
1	Peritonitis 03/2010
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2010
1	Invasive Fungal Infections 03/2010

4	NestinIBA 07/2016 - 01/2011
2	Sunitinib (Sutent)FDA Link 07/2021 - 09/2018
2	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2019 - 01/2019
2	VaccinesIBA 01/2019 - 01/2019
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 09/2018 - 10/2017
1	lorlatinibIBA 01/2022
1	Denosumab FDA Link 07/2021
1	PhosphoproteinsIBA 07/2021
1	Monoclonal AntibodiesIBA 07/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2019
1	Vasopressins (Vasopressin)IBA 11/2019
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2019
1	AutoantigensIBA 01/2019
1	AntigensIBA 01/2019
1	pazopanib FDA Link 01/2019
1	Cancer VaccinesIBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2018
1	Phosphotransferases (Kinase)IBA 09/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2018
1	Voriconazole (Vfend)FDA LinkGeneric 01/2017
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2011
1	Colloids (Colloid)IBA 03/2010
1	efungumabIBA 03/2010
1	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2010